Ultrasound-guided high-intensity focused ultrasound treatment for abdominal wall endometriosis: a retrospective study

Sheng‐Dean Luo, Luo S, S Luo, Cai Zhang, C. Zhang, J P Huang, Huang JP, JP Huang, G H Huang, G-H Huang, Huang GH, He J, Jia He, J He
BJOG: An International Journal of Obstetrics & Gynaecology · 2017 · vol. 124(S3) , pp. 59–63 · doi:10.1111/1471-0528.14741 · PMID:28856852 · W2750699795
Other OA: bronze CC0 ⤵ 28 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Ultrasound-guided high-intensity focused ultrasound effectively ablated abdominal wall endometriosis lesions, significantly reducing lesion volume and pain scores with only temporary local edema and no severe complications.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To evaluate the safety and efficacy of ultrasound-guided high-intensity focused ultrasound (USgHIFU) for treating abdominal wall endometrioses (AWE). DESIGN: A retrospective study. SETTING: Department of Obstetrics and Gynaecology in China. POPULATION: Patients with abdominal wall endometriosis. METHODS: From August 2010 to April 2014, 32 patients with AWE were treated with USgHIFU in our hospital. USgHIFU treatment was performed with the Model JC-200 High Intensity Focused Ultrasound Tumor Therapeutic System. The symptom relief and the adverse effects were evaluated after USgHIFU ablation. MAIN OUTCOME MEASURES: USgHIFU as a new treatment option for patients with AWE. RESULTS: Contrast-enhanced ultrasound showed that all lesions were successfully ablated with USgHIFU. The follow-up results showed that the average volume of AWE lesions at 6 months after USgHIFU was significantly smaller than that before treatment (2.80 ± 0.12 versus 1.33 ± 0.31 cm3 ). The pain scores at 6 months after treatment were significantly lower than those before treatment (6.80 ± 2.64 versus 1.80 ± 0.3). The non-perfused volume (indicative of successful ablation) was measured in all patients immediately after treatment, ranging from 0.9 to 2.1 cm3 (median: 1.6 cm3 ), and the fractional ablation ranged from 87% to 100% (median: 94%). Local oedema was observed in these patients, lasting for 1-3 days only. No severe complications occurred during the follow-up period. CONCLUSIONS: Based on our study, USgHIFU ablation is a safe and effective method for treating AWE. TWEETABLE ABSTRACT: As a non-invasive treatment technique, HIFU could be used to treat abdominal wall endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Abdominal Wall Endometriosis High-Intensity Focused Ultrasound Ablation Muscular Diseases Abdominal Wall Abdominal Wall Adult Adult Endometriosis Endometriosis Female Female High-Intensity Focused Ultrasound Ablation High-Intensity Focused Ultrasound Ablation High-Intensity Focused Ultrasound Ablation Humans Humans Muscular Diseases Muscular Diseases Operative Time

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (19)

Cited by (26)

Source provenance

europepmc
last seen: 2026-10-13T06:10:10.580696+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:20:29.702106+00:00
License: CC0 · commercial use OK